BEONE MEDICINES LTD. Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
BEONE MEDICINES LTD. (ONC) had Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss of $2.56 million as of 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss · last filed 2024-02-26
- 2023-12-31: Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss $2.56M.
- 2023-09-30: Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss $107.78M.
- 2023-06-30: Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss $107.80M.
- 2023-03-31: Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss $298.01M.
| Period end | Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss |
|---|---|
| 2023-12-31 | $2.56M 10-K · filed 2024-02-26 |
| 2023-09-30 | $107.78M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $107.80M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $298.01M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $674.26M 10-K · filed 2024-02-26 |
| 2022-09-30 | $883.13M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.18B 10-Q · filed 2022-08-08 |
| 2021-12-31 | $2.25B 10-K · filed 2023-02-27 |